Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction

By Y. Miyahara, N. Nagaya, M. Kataoka, B. Yanagawa, Koichi Tanaka, Hiroyuki Hao, K. Ishino, H. Ishida, Tatsuya Shimizu, K. Kangawa and 4 more. Nature Medicine, 2006

1,211 citations recorded by the source corpus.

Subfields: Biomaterials, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/b01d848cfe5d9fa5bd5dd1e31b07eaeb5abd65d5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. J. Karp
2. R. Lee

In Genetics

1. Michael A. Matthay
2. T. Suda
3. C. Gregory
4. Jeffrey L Spees
5. J. Karp
6. R. Lee
7. R. Zemans

In Surgery

1. C. Gregory
2. Michael A. Matthay
3. Jeffrey L Spees
4. J. Karp
5. R. Lee

Citations in the corpus

• Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease (2012, methodology): “Another approach for increasing secretion of paracrine factors involves culturing monolayers of rat-adipose-tissue-derived MSC sheets, prepared by incubating rMSC monolayers within temperatureresponsive dishes at 20 C for about 40 min and detaching them into monolayers of rMSC sheets (Miyahara et al”
• Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow (2009, background): “Recent studies consistently show that MSCs not only differentiate into mesenchymal lineage cells but also into neurons (Kohyama et al., 2001; Kondo et al., 2005), skeletal muscle (Dezawa et al., 2005), and myocardium (Makino et al., 1999; Miyahara et al., 2006).”
• Mechanisms of mesenchymal stem/stromal cell function (2016, background): “diac repair have been proposed, including secretion of angiogenic factors [87–89], stromal cell derived factor-1”
• Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung (2009, background): “Recent studies have suggested that bone marrow-derived multipotent mesenchymal stem cells (MSCs) may have therapeutic applications in several clinical disorders including myocardial infarction (17), diabetes (18), sepsis (19), hepatic (20), and acute renal failure (21).”
• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 (2007, methodology): “(35) isolated MSC from adipose tissue of rats, and similar to Kotton et al.”
• 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair. (2017, methodology): “Towards the enhancement of therapeutic efficacy, th ere ave been numerous approaches for promoting high cell survival via delivering of cells with functional biomaterials[4, 5], proangiogenic factors[6, 7], and genetically modified cells[8, 9], or using sheet type carriers[10].”